Next Article in Journal
Wnt Signaling and Its Impact on Mitochondrial and Cell Cycle Dynamics in Pluripotent Stem Cells
Next Article in Special Issue
Dynamin-Related Protein 1 at the Crossroads of Cancer
Previous Article in Journal
Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology
Previous Article in Special Issue
RhoB: Team Oncogene or Team Tumor Suppressor?
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessReview
Genes 2018, 9(2), 108; https://doi.org/10.3390/genes9020108

Glutamine Synthetase: Localization Dictates Outcome

1
Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari 70125, Italy
2
Hematology Unit, National Cancer Research Center, Istituto Tumori 'Giovanni Paolo II', Bari 70124, Italy
*
Author to whom correspondence should be addressed.
Received: 20 January 2018 / Revised: 14 February 2018 / Accepted: 15 February 2018 / Published: 19 February 2018
View Full-Text   |   Download PDF [769 KB, uploaded 22 February 2018]   |  

Abstract

Glutamine synthetase (GS) is the adenosine triphosphate (ATP)-dependent enzyme that catalyses the synthesis of glutamine by condensing ammonium to glutamate. In the circulatory system, glutamine carries ammonia from muscle and brain to the kidney and liver. In brain reduction of GS activity has been suggested as a mechanism mediating neurotoxicity in neurodegenerative disorders. In cancer, the delicate balance between glutamine synthesis and catabolism is a critical event. In vitro evidence, confirmed in vivo in some cases, suggests that reduced GS activity in cancer cells associates with a more invasive and aggressive phenotype. However, GS is known to be highly expressed in cells of the tumor microenvironment, such as fibroblasts, adipocytes and immune cells, and their ability to synthesize glutamine is responsible for the acquisition of protumoral phenotypes. This has opened a new window into the complex scenario of the tumor microenvironment, in which the balance of glutamine consumption versus glutamine synthesis influences cellular function. Since GS expression responds to glutamine starvation, a lower glutamine synthesizing power due to the absence of GS in cancer cells might apply a metabolic pressure on stromal cells. This event might push stroma towards a GS-high/protumoral phenotype. When referred to stromal cells, GS expression might acquire a ‘bad’ significance to the point that GS inhibition might be considered a conceivable strategy against cancer metastasis. View Full-Text
Keywords: glutamine; glutamine synthetase; M2 macrophages; adipocytes; immunosuppressive; glutaminase; cancer; brain; metabolism; immunometabolism glutamine; glutamine synthetase; M2 macrophages; adipocytes; immunosuppressive; glutaminase; cancer; brain; metabolism; immunometabolism
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Castegna, A.; Menga, A. Glutamine Synthetase: Localization Dictates Outcome. Genes 2018, 9, 108.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top